Patient Care

Patient Care Collage

 

Patient Care

AIDS-Related Eye Problems

Allergic Conjunctivitis

Amblyopia (lazy eye)

Aniridia

Astigmatism

Bags (fat prolapse)

Blepharitis

Blepharospasm

Cataract

Chalazion

Color Blindness

Conjunctivitis (pink eye)

Diabetic Retinopathy

Double Vision (diplopia)

Dry Eye

Fetal Alcohol Syndrome

Floaters

Genetic Eye Disorders

Glaucoma

Graves' Disease

Herpes

Hyperopia

Ischemic Optic Neuropathy

Keratitis (corneal infection)

Keratoconus

Low Vision

Lyme Disease

Macular Degeneration

Macular Hole

Melanoma

Migraine (headache)

Myasthenia Gravis

Myopia (nearsightedness)

Nystagmus

Optic Neuritis

Pterygium

Ptosis (drooping eyelid)

Retinal Detachment

Retinitis Pigmentosa

Retinopathy of Prematurity

Shingles

Sports Eye Injuries

Strabismus

Stye

Systemic Disease and the Eye

Tearing

Thyroid Eye Disease

Trauma

Uveitis

Wrinkles


 

Eye Conditions

Macular Degeneration

Macular degeneration affects the macula, the tiny central area of the retina. The macula provides central vision, which is essential for seeing fine detail, looking straight at an object, reading, and driving. Although patients with macular degeneration retain their peripheral, or side vision, the absence of central vision can be a severe handicap. Age-related macular degeneration is a leading cause of legal blindness, one of the criteria being central vision of 20/200 or worse in the better eye with corrective eyeglasses.

Signs and Symptoms

  • Vision becomes blurry or distorted

  • Words seem to crowd together, declined reading ability

  • Eyeglasses do not help

  • Diagnosis made using an Amster grid

Treatments and Prevention

  • Laser Treatment

UIC Specialists
Norman Blair, MD

Michael Shapiro, MD
Lawrence Ulanski, MD
Any Vitreoretinal Specialist

Treatment Clinic/Service
Vitreoretinal Service

Clinical Treatment and Trials
AGE-RELATED MACULAR DEGENERATION
Phillip J. DeChristoper, MD, PhD, Principal Investigator
Jose Pulido, MD, MS; Steve Sossler, PhD, Co-Investigators

SPONSOR: Apheresis Technologies, Palm Harbor, Florida
TITLE: A multicenter, prospective randomized double-masked study comparing the safety and efficacy of membrane differential filtration to a placebo treatment in patients with non-exudative age-related macular degeneration
Study Coordinator: Maria Tousa

This information is not intended to replace the advice of a doctor.

 

Contact Us  |  Email Webmaster  |  Notice of Privacy Practices  |  Link to UICCollege of Medicine The Eye Digest
© 2008 UIC Board of Trustees
UIC Web Privacy Notice
All Rights Reserved